secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001628280-24-007195
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agilon health Q4 net loss $230M, medical margin negative $102M; FY2024 guidance slashed
--------------------------------------------------------------------------------

- Q4 revenue $1.06B (+72% YoY) but gross profit of negative $95M vs $16M a year ago.
- Full-year 2023 net loss $263M vs $107M in 2022; Adjusted EBITDA loss $95M.
- Medical margin for Q4 negative $102M; FY2023 $299M vs guidance midpoint $350M.
- FY2024 medical margin guidance cut to $400-450M from prior $560-600M; Adj. EBITDA now loss of $60-15M vs prior profit $40-60M.
- Class of 2025 adds at least 60K MA members across 5 physician groups; entry costs lowered to $55-65M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/0001628280-24-007195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828024007195/agl-20240227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-007195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer